SPP1 promoter polymorphisms and glioma risk in a Chinese Han population

Journal of Human Genetics

Volumn 55, Issue 7, 2010, Pages 456-461

  Chen, Juxiang ^a   Wu, Qihan ^b   Lu, Yicheng ^a   Xu, Tao ^a   Huang, Yan ^c   Ribas, Judit ^d   Ni, Xiaohua ^d   Hu, Guohan ^a   Huang, Fengping ^e   Zhou, Liangfu ^e   Lu, Daru ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e FUDAN UNIVERSITY   (China)

Author keywords

association study; glioma; polymorphism; promoter; SPP1

Indexed keywords

MESSENGER RNA; OSTEOPONTIN;

ADULT; ARTICLE; CANCER RISK; CELL ASSAY; CHILD; CHINESE; CONTROLLED STUDY; ETHNIC GROUP; FAMILY HISTORY; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC TRANSCRIPTION; GENOTYPE; GLIOMA; GLIOMA CELL; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION GENETICS; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HAPLOTYPES; HUMANS; MALE; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; TRANSCRIPTION, GENETIC;

EID: 77955008726     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.48     Document Type: Article

References (28)

1. Denhardt, D. T., O'Regan, A. W., Pavlin, D. & Berman, J. S. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107, 1055-1061 (2001).
2. Matusan-Ilijas, K., Behrem, S., Jonjic, N., Zarkovic, K. & Lucin, K. Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma. Pathol. Oncol. Res. 14, 293-298 (2008).
3. Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S. et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287, 860-864 (2000).
4. Agnihotri, R., Crawford, H. C., Haro, H., Matrisian, L. M., Havrda, M. C. & Liaw, L. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J. Biol. Chem. 276, 28261-28267 (2001).
5. Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C., Rittling, S. R., Denhardt, D. T. et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294, 1731-1735 (2001).
6. Chiocchetti, A., Indelicato, M., Bensi, T., Mesturini, R., Giordano, M., Sametti, S. et al. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood 103, 1376-1382 (2004).
7. Jang, T. C., Savarese, T., Low, H. P., Kim, S., Vogel, H., Lapointe, D. et al. Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. Am. J. Pathol. 168, 1676-1685 (2006).
8. Saitoh, Y., Kuratsu, J., Takeshima, H., Yamamoto, S. & Ushio, Y. Expression of osteopontin in human glioma. Its correlation with the malignancy. Lab. Invest. 72, 55-63 (1995).
9. Gunnersen, J. M., Spirkoska, V., Smith, P. E., Danks, R. A. & Tan, S. S. Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expressin. Glia 32, 146-154 (2000).
10. Hijiya, N., Setoguchi, M., Matsuura, K., Higuchi, Y., Akizuki, S. & Yamamoto, S. Cloning and characterization of the human osteopontin gene and its promoter. Biochem. J. 303, 255-262 (1994).
11. Kim, H. J., Lee, M. H., Kim, H. J., Shin, H. I., Choi, J. Y. & Ryoo, H. M. Okadaic acid stimulates osteopontin expression through de novo induction of AP-1. J. Cell. Biochem. 87, 93-102 (2002).
12. Renault, M. A., Jalvy, S., Belloc, I., Pasquet, S., Sena, S., Olive, M. et al. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells. Circ. Res. 93, 674-681 (2003).
13. Sakata, R., Minami, S., Sowa, Y., Yoshida, M. & Tamaki, T. Trichostatin A activates the osteopontin gene promoter through AP1 site. Biochem. Biophys. Res. Commun. 315, 959-963 (2004).
14. Inman, C. K. & Shore, P. The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. J. Biol. Chem. 278, 48684-48689 (2003).
15. Giacopelli, F., Marciano, R., Pistorio, A., Catarsi, P., Canini, S., Karsenty, G. et al. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol. Genomics 20, 87-96 (2004).
16. D'Alfonso, S., Barizzone, N., Giordano, M., Chiocchetti, A., Magnani, C., Castelli, L. et al. Two single-nucleotide polymorphisms in the 5¢ and 3¢ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 52, 539-547 (2005).
17. Hummelshoj, T., Ryder, L. P., Madsen, H. O., Odum, N. & Svejgaard, A. A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression. Mol. Immunol. 43, 980-986 (2006).
18. Brenner, D., Labreuche, J., Touboul, P. J., Schmidt-Petersen, K., Poirier, O., Perret, C., et al., GENIC Investigators Cytokine polymorphisms associated with carotid intimamedia thickness in stroke patients. Stroke 37, 1691-1696 (2006).
19. Liu, Y., Zhang, H., Zhou, K., Chen, L., Xu, Z., Zhong, Y. et al. Tagging SNPs in nonhomologous end-joining pathway genes and risk of glioma. Carcinogenesis 28, 1906-1913 (2007).
20. Hendig, D., Arndt, M., Szliska, C., Kleesiek, K. & Götting, C. SPPI promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum. Clin. Chem. 53, 829-836 (2007).
21. Bellahcène, A., Castronovo, V., Ogbureke, K. U., Fisher, L. W. & Fedarko, N. S. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat. Rev. Cancer 8, 212-226 (2008).
22. Brown, L. F., Berse, B., Van De Water, L., Papadopoulos-Sergiou, A., Perruzzi, C. A., Manseau, E. J. et al. Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces. Mol. Biol. Cell. 3, 1169-1180 (1992).
23. Fisher, J. L., Schwartzbaum, J. A., Wrensch, M. & Wiemels, J. L. Epidemiology of brain tumors. Neurol. Clin. 25, 867-890 (2007).
24. Denhardt, D. T. & Guo, X. Osteopontin: a protein with diverse functions. FASEB J. 7, 1475-1482 (1993).
25. Dreier, B., Beerli, R. R., Segal, D. J., Flippin, J. D. & Barbas, C. F. Development of zinc finger domains for recognition of the 5 ¢-ANN-3¢ family of DNA sequences and their use in the construction of artificial transcription factors. J. Biol. Chem. 276, 29466-29478 (2001).
26. Zhang, R., Min, W. & Sessa, W. C. Functional-analysis of the human endothelial nitricoxide synthase promoter - SP1 and gata factors are necessary for basal transcription in endothelial-cells. J. Biol. Chem. 270, 15320-15326 (1995).
27. Ito, Y. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv. Cancer Res. 99, 33-76 (2008).
28. Armstrong, R. C., Migneault, A., Shegog, M. L., Kim, J. G., Hudson, L. D. & Hessler, R. B. High-grade human brain tumors exhibit increased expression of myelin transcription factor 1 (MYT1), a zinc finger DNA-binding protein. J. Neuropath Exp. Neur. 56, 772-781 (1997).